Keyphrases
Orphan Medicinal Product
100%
Medical Conditions
62%
Condition-dependent
45%
Clinical Features
45%
Methodological Uncertainty
40%
Regulatory Decision Making
40%
Europe
40%
Surgical Patients
40%
Chronic Medication
40%
Drug Development
40%
Asterix
40%
Multiple Correspondence Analysis
40%
Therapeutic Program
40%
Clinical Pharmacist
40%
Successful Integration
40%
Outpatient Parenteral Antibiotic Therapy
40%
Relevant Dimension
25%
Small Populations
25%
Product Basis
25%
Market Access
25%
EU Legislation
25%
Medication Omission
20%
Access to New Drugs
20%
Cost-effective Design
20%
Optimal Fit
20%
Pharmaceutical Intervention
20%
Medical Staff
20%
Acceptance Level
20%
Hospitalization
20%
Underlying Pathology
20%
Healthcare Professionals
20%
Dictionary
20%
Clinical Conditions
20%
Clinical Development
20%
Disease Conditions
20%
Patient Needs
20%
Pharmaceutical Industry
20%
Potential Characteristics
20%
Methodological Decisions
20%
Orphan Drugs
20%
Clinical Validation
20%
Prevalent Diseases
20%
Clinical Trial Methodology
20%
Expert Clinician
20%
Disease Classification
17%
Pivotal Trial
17%
Multidisciplinary Team
15%
European Public Assessment Report
11%
Progressive Conditions
11%
Disease Pattern
11%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Feature
80%
Disease
80%
Clinical Trial
60%
Prospective Study
40%
Drug Development
40%
Antimicrobial Therapy
40%
Adverse Event
40%
Base
40%
Isoniazid
40%
Disease Classification
24%
Orphan Drug
20%
Infection
15%
Antiinfective Agent
10%
Rare Disease
8%
Intravenous Route
5%
Combination Therapy
5%
